Cancer Research AACR Conference on Molecular Diagnostics - 2008  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 24, 61-63, January 1, 1964]
© 1964 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dietrich, L. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dietrich, L. S.

Augmentation of 6-Aminonicotinamide Antagonism of Tumor Growth by Compounds with Estrogenic Activity*

L. S. Dietrich

( Department of Biochemistry, University of Miami, School of Medicine, Miami, Florida)

The hormonal derivatives diethylstilbestrol, hexestrol, dienestrol, cortisone, estradiol-17{alpha}, estradiol-17ß, progesterone, and phloretin were compared with regard to their capacity to enhance carcinostasis in the presence of the niacin antagonist 6-aminonicotinamide. Diethylstilbestrol and hexestrol were found to be more powerful than either estradiol-17ß or dienestrol. Phloretin, estradiol-17{alpha}, and progesterone were without activity.

Cortisone, either alone or in the presence of 6-aminonicotinamide, exhibited slight antitumor activity.

In the absence of 6-aminonicotinamide, diethylstilbestrol, hexestrol, dienestrol, and estradiol-17ß had no antitumor activity.

The suggestive correlation between estrogenic activity and enhancement of carcinostasis in the presence of 6-aminonicotinamide is discussed.

* This work was supported in part by Grant CY-4868 and a Career Development Award GM-K3-15, 186 from the United States Public Health Service.

Received 7/ 5/63.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1964 by the American Association for Cancer Research.